First Turn Management’s Olema Pharmaceuticals OLMA Stock Holding History
Bought
Maintained
Sold
Other funds holding OLMA
PBA
JT
BCLSI
BI
SL
LGM
First Turn Management's OLMA Position: Q2 2026 in Review
First Turn Management sold out of Olema Pharmaceuticals (OLMA) in Q2 2026, closing a stake of 768,662 shares — an estimated $11.5M sold.
First Turn Management first reported a position in OLMA in Q4 2025 and held it in 2 quarters. The position peaked at $15.4M in Q4 2025. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.
- First Turn Management reported no remaining Olema Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- First Turn Management sold 768,662 Olema Pharmaceuticals shares in Q2 2026, an estimated $11.5M.
- First Turn Management first reported a position in Olema Pharmaceuticals in Q4 2025 and held it in 2 quarters.
- First Turn Management's Olema Pharmaceuticals position peaked at $15.4M in Q4 2025.
- 185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.
Based on First Turn Management's 13F filing for Q2 2026, filed 14 Aug 2026.